A Novel Approach of Gastroretentive Drug Delivery : In Situ Gel
DOI:
https://doi.org/10.56511/JIPBS.2014.v1.i01.pp39-59Abstract
Over the past few decades, advances in in situ gel technologies have spurred development in many medical and biomedical applications including controlled drug delivery. Many novel in situ gel-based delivery matrices have been designed and fabricated to fulfill the ever-increasing needs of the pharmaceutical and medical fields. In situ gelling systems are liquid at room temperature but undergo gelation when in contact with body fluids or change in pH. In situ gel forming drug delivery is a type of mucoadhesive drug delivery system. The formation of gel depends on factors like temperature modulation, pH change, presence of ions and ultra violet irradiation from which the drug gets released in a sustained and controlled manner. Many natural, biodegradable, biocompatible and synthetic polymers like alginic acid, pluronic F127, xyloglucan, gellan gum, carbopol, pectin, chitosan, poly (DL lactic acid), poly (DL-lactide-coglycolide) and poly-caprolactone etc. are used in the preparation of in situ gelling system. Mainly in situ gels are administered by oral, ocular, rectal, vaginal, injectable and intraperitoneal routes. In situ gelling system becomes very popular nowadays because of their several advantages over conventional drug delivery systems like sustained and prolonged release of drug, reduced frequency of administration, improved patient compliance and comfort.
Keywords:
Gastro retention, Floating In situ gel, Stomach specific drug delivery, sustained release, biodegradable polymers, floating drug deliveryDownloads
References
Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. In situ-gelling gellan formulations as vehicles for oral drug delivery. J Control Rel. 1999; 60:287-95
Miyazaki S, Endo K,Kawasaki N, Kubo W, Watanabe H, Attwood D. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev Ind. Pharm. 2003; 29 (2):113-9.
Peppas N, Langer R. New challenges in biomaterials. Science1994; 263:17152
A. Rozier, C. Mazuel, J. Grove, B. Plazonnet, Gelrite: A novel, ionactivated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int. J. Pharm. 1989; 57 163 – 168.
S. Cohen, E. Lobel, A. Trevgoda, Y. Peled. A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J. Control. Release. 1997; 44 201 – 208.
B. Srividya, R.M. Cardoza, P.D. Amin. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J. Control Release. 2001;73: 205 – 211.
S. Miyazaki, N. Kawasaki, K. Endo, D. Attwood. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits. J. Pharm. Pharmacol. 2001; 53: 1185 – 1191.
S. Miyazaki, S. Suzuki, N. Kawasaki, K. Endo, A. Takahashi, D. Attwood. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int. J. Pharm. 2001; 229: 29 – 36.
S. Miyazaki, F. Suisha, N. Kawasaki, M. Shirakawa, K. Yamatoya, D. Attwood. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J. Control. Release. 1998; 56:75 – 83.
Himanshu Gupta , Aarti Sharma. Ion activated bioadhesive in situ gel of clindamycin for vaginal application. International Journal of Drug Delivery. 2009; 1: 32-40
U.V. Singh, N. Udupa, R. Kamath, P. Umadevi, Enhanced Biodegradable in situ forming implants and methods of antitumor efficacy of methoteraxate poly(lactic-co-glycolic) producing the same, US Pat. 4938763, 3 July 1990. acid injectable gel implants in mice bearing sarcoma-180, 136.
F. Suisha, N. Kawasaki, S. Miyazaki, M. Shirakawa, K. Yamatoya, M. Sasaki, D. Attwood, Xyloglucan gels as sustained release vehicles for the intraperitoneal administration ofmitomycin C. Int. J. Pharm. 1998 ; 172: 27 – 32
Lathori S.R, Syed Iftequar M, Dehghan M.H, Shoaib S, Mohiuddin S, An Overview of gastroretentive drug delivery system research. International Research Journal of Pharmacy,2(11),2011,50-57.
Nayak Amitkumar, Maji Ruma, Das Biswarup, Gastroretentive drug delivery systems: A review. Asian Journal of Pharmaceutical and Clinical Research, Vol.3, Issue 1, JanuaryMarch 2010, 1-10.61-63
Patel Nirav, Nagesh C, Chandrashekhar S, Patel jinal, Jani Devdatt, Floating drug delivery system: An innovative acceptable approach in Gastro retentive drug delivery. Asian J. Pharm. Res, 2012, Vol 2,Issue I, 7-18
Ramdas T. Dolas, Dr. Avanish Hosmani, Dr. Anil Bhandari, Novel sustained release gastroretentive drug delivery system: A review. International Journal of Pharma. Research & Development, Vol-2,Issue-II, 2011, 26-41.
R. Vinod, Vasal Santhosh, Anbuazaghan, Banjil David, A. Padmasri, Approaches for gastroretentive drug delivery systems. International Journal of Applied Biology and Pharmaceutical technology,Vol-1,Issue-2, Aug-Oct-2010,589-601
Wu, C., H. Qi, W. Chen, C. Huang, C. Su, W. Li andS. Hou, Preparation and evaluation of a carbopol/hpmc based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi, Pharmaceutical Society of Japan, 127(1): 2007. 183-191
H.V.Rathod, H., V. Patel and M. Modasia, In situ gel as a novel approach of gastroretentive drug delivery. International Journal Of Pharmacy and Life Sciences,1(8): 2010 . 440-447.
Seth SD.Text book of pharmacology, Reed Elsevier Ltd.2005
Shah, D.P. and G.K. Jani, A newer application of physically modified gellan gum in tablet formulation using factorial design. ARS Pharmaceutica, 51(1): 2010. 28-40.
Patel, J.K., J.R. Chavda and M.K. Modasiya, Floating in situ gel based on alginate as carrier for stomach-specific drug delivery of famotidine International Journal Of Pharmaceutical Sciences, 3(3): 2010.10921104.
Ganapati, R., K.S. Bhimagoni and S. Anegundha,. Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation. Acta Pharmceutica, 59: 2007345-354.
Nagarwal, R.C., A. Srinatha and J.K. Pandit, In situ forming formulation: development, evaluation and optimization using 33 factorial design. AAPS Pharmscitech, 10(3): 2009 977 - 984.
Rajinikanth, P.S., J. Balasubramaniam and B. Mishra Development and evaluation of a novel floating in situ gelling system of a moxicillin for eradication of Helicobacter pylori. International Journal of Pharmaceutics, 335: 2007.114 - 122.
Shah, D.P. and G.K. Jani,. A newer application of physically modified gellan gum in tablet formulation using factorial design. ARS Pharmaceutica, 51(1): 2010.28 - 40.
Schmolka IR, Artificial skin, Preparation and properties of pluronic F127 gels for the treatment of burns, J.Biomed. Mater. Res, 1972, 6, 571 - 582
Kabanov A, Batraoka E, Alakhov V, Pluronic block copolymers as novel polymer therapeutics f or oral and gene Delivery, J. Co ntrol. Rel, 2002, 82, 189 - 212.
Carelli V, Coltelli S, Di Colo G, Nannipieri E, Serafini MF,Silicone microspheres for PH controlled gastrointestinal drug Delivery, Int J Pharm, 1999, 17, 73 - 83
Kubo W, Miyazaki S, Attwood D, Oral sustained delivery of paracetamol from in situ gelling gellan and sodium alginate Formulations, Int J Pharm., 2003, 258, 55 - 64 56.
Schoenwala RD, Smlen VF, Drug absorption analysis from Pharmacological data: Transcorneal biophasic availability of trop icamide, J Pharm Sci, 1971, 60, 1039 -
Durrani A.M, Davies N.M, 33.Thomas M, Kellaway I.W, Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug deli. Sys, International Journal of Pharmaceutics, 1992, 88, 409, Chrai S.S et al, J.Pharm. Sci, 1973, 62,1112-1121
Alder, C.A, Maurice, D.M & Paterson, M. EExp. Eye Res, 1971,11, 34-42
Patton T.F, Robinson J.R, J. Pharm. Sci, 1975, 64, 1312-1315
Choi HG, Oh YK, Kim CK., In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability, Int J Pharm, 1998, 165, 23-32
Liaw, J, Robinson J, Rin mitra, A.K. ed, ophthalmic drug delivery system, 1993, 369-
Vermani K, Garg S, The scope and potential of vaginal drug delivery, Pharm Sci & Technol Today, 2000, 3, 359-364
Chang JY, Oh YK, Kong HS, Kim EU, Jang DD, Nam KT,Prolonged antifungal effects of clotrimazolecontaining Mucoadhesive thermosensitive gels on vaginitis, J Control Release, 2002, 82, 39-50
Ricci EJ, Bentley MV, Farah M, Bretas RES, Marchetti JM, Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels, Eur J Pharm Sci, 2007, 17, 161-167
Paavola AY, liruusi J, Rosenberg P, Controlled release and dura mater permeability of lidocaine and ibuprofen from Injectable poloxamer-based gels, J Control Release, 1998, 52, 169-178
Barichello JM, Morishita M, Takayama K, Nagai T, Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats, Int J Pharm, 1999, 184, 189198
Katakam M, Ravis WR, Banga AK., Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels, J Control Release, 1997, 49, 21-26
DesNoyer JR, McHugh AJ, The effect of Pluronic on the proteinrelease kinetics of an Injectable drug delivery system,J Control Release, 2003, 86, 15-24
Kim YJ, Choi S, Kohl JJ, Lee M, Kim SW. Controlled release of insulin from Injectable biodegradable triblock Copolymer, Pharm. Res, 2001; 18:548-550
Jeong B, Bae YH, Lee DS, Kim SW, Biodegradable block copolymers as injectable drug delivery systems, Nature,1997, 388, 860-862
Miyazaki S, Tobiyama T, Takada M, Attwood D, Percutaneous absorption of indomethacin from pluronic F127 gels in rats, J Pharm Pharmacol, 1995, 47, 455-457
Pillai O, Panchagnula R, Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeationstudies in rat using iontophoresis and chemical enhancers, J Control Release, 2003, 89, 127-
Kashyap N., Viswanad B., Sharma G., Bhardwaj V., Ramarao P. and Kumar M.N. Design and evaluation of biodegradable, biosensitive in situ gelling systems for pulsatile delivery of insulin. Biomaterials, 2007, 28:2051 2060.
Shah SH, Patel JK, Patel NV. Gastroretentive floating drug delivery systems with potential herbal drugs for Helicobacter pylori eradication: a review J Chin Integr Med. 2009; 7(10): 976-982
Bhimani RD, Patel JK, Patel VP.Devlopment and evalutionfloting in situ gel of clarithromycin.Int J of Pharm Res, 2011, 3, 32-35
Shreeraj Shah, Pratik Upadhyay, Darsh Parikh, Jinal Shah.In Situ Gel: A Novel Approach of gastro retentive Drug Delivery. Asian Journal of Biomedical and Pharmaceutical Sciences, 2012,2, 01-08
Asfaw, Bruktawit T.Jackson, John C.Lu, ZhihuaZhai, XiaowenShums, SameerHirt, ThomasHu, Xianbo René, Claude-raymond, In situ forming hydrogel wound dressing containing antimicrobial agents, USpatent 0009275, Jun 28, 2011. 25-263
Gillian Eccleston, Ronald Paterson, Gastric raft composition, USpatent 0063980, Oct 29, 2002.
Yawei Ni, Kenneth M. Yates In situ gelation of pectin substance, US patent 01199941, February 28, 2001.
Claire Haug, Stephane Jonat, In situ gelling systems as sustained delivery for front of eye, US patent 0082221, Jun 11, 2009.
Garg S. and Sharma S. Gastroretentive Drug Delivery System, Business Briefing: Pharmatech , 2003, 160-166 .
Strübing S, Abbouda T, Renata C, Metza H. New insights on poly (vinyl acetate)-based coated floating tablets: Characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. European J.Pharm.and Biopharm, 69, 2008, 708-717.
Janga S, Lee J, Park S. Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis. Int.J.Pharm , 356, 2008, 88-94.
Rajinikanth P. and Mishra B. Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H.pylori. J.Cont.Rel , 25, 2008, 33-41.
Vyas SP, Khar RK. Gastroretentive systems. In: Controlled drug Delivery. Vallabh Prakashan, Delhi, India. 2006. p.197-217.
Chawla G, Gupta P, Bansal AK. Gastroretentive drug delivery systems. In: Jain NK (Ed). Progress in controlled and novel drug delivery systems. CBS Publishers and Distributors. New Delhi. 2004. p.76-97.
Published
How to Cite
Issue
Section
Copyright (c) 2014 Swapnali R. Shinde, Preeti Sable, Babita B. Lodhi, Sarfaraz Khan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at